- Recent Funding
- Investors
- Questa Capital Management
Questa Capital Management portfolio
Questa Capital Management has 4 portfolio companies on record at Recent Funding.
About this page
It is a venture capital firm based in San Francisco, US, founded in 2016. It led 4 of the 6 rounds it joined. Its most recent investment on record is EnsoData's $20M Series B+ round in June 2025, which it led. By category, its portfolio leans toward Health and bio (4) and Education (2). It has co-invested with ARTIS Ventures, NTT Venture Capital and Highland Capital Partners, most often ARTIS Ventures (2 rounds).
About Questa Capital Management
Funds raised
| Fund | Fund # | Size | Announced |
|---|---|---|---|
Bay Area | Ifirst fund | Not shown |
What Questa Capital Management invests in
- Health and bio · 4 · 100%
- Education · 2 · 50%
- Data and analytics · 1 · 25%
Questa Capital Management recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $20M · lead | none named | ||
| Series B+ · $41M | LG Technology Ventures, What If Ventures, ARTIS Ventures +4 | ||
| Series B+ · $18M · lead | Panache Ventures, Resolve Growth Partners, MaRS Investment Accelerator Fund +1 | ||
| Series B+ · $80M | Advent Life Sciences (lead), Emerson Collective, SoftBank Vision Fund +7 | ||
| Series B+ · $38M · lead | Cedar Mundi Ventures, Global Ventures, Maverick Ventures (lead) +3 | ||
| Series B+ · $65M · lead | ARTIS Ventures, Longevity Vision Fund, NTT Venture Capital +4 |
How Questa Capital Management invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 6 100% | $262M |
Questa Capital Management portfolio companies
EEnsoData$20MSeries B+ · Jun 2025
EEko Health$41MSeries B+ · Jun 2024
AACTO$18MSeries B+ · Jul 2022
PProximie$80MSeries B+ · Jun 2022
| Company | Round with Questa Capital Management | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $20M · lead | $20M | Jun 15, 2026 Series A |
Health and bio |
Series B+ · $41M | $133.8M | Jul 18, 2024 Series B+ |
Health and bio |
Series B+ · $18M · lead | $33.5M | Feb 1, 2024 Seed |
Health and bio |
Series B+ · $80M | $118M | Sep 18, 2024 Series B+ |
Most frequent co-investors
AARTIS Ventures2 shared rounds · last Jun 1, 2024
NNTT Venture Capital2 shared rounds · last Jun 1, 2024
HHighland Capital Partners2 shared rounds · last Jun 1, 2024
MMaverick Ventures2 shared rounds · last Jun 1, 2022EEight Roads Ventures2 shared rounds · last Jun 1, 2022
FF-Prime Capital2 shared rounds · last Jun 1, 2022
GGlobal Ventures2 shared rounds · last Jun 1, 2022
LLG Technology Ventures1 shared round · last Jun 1, 2024
EEDBI1 shared round · last Jun 1, 2024
WWhat If Ventures1 shared round · last Jun 1, 2024
DDouble Point Ventures1 shared round · last Jun 1, 2024
SSalesforce Ventures1 shared round · last Jul 8, 2022
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
CCambridge Enterprise Ventures5 companies · 3 deals in 12 mo
HHealthier Capital5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Venture funds Questa Capital Management raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.
Share is of the 6 rounds on Recent Funding that name Questa Capital Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Questa Capital Management, which is a subset of its real portfolio. API: /api/v1/investors/questa-capital-management (get a free API key). More: the most active VC firms and new venture capital funds.